Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05566964 · ClinicalTrials.gov registry record

Descriptive Analysis of Real-world Data Collected with ME&MGopen

A clinical trial, sponsored by Ad scientiam.

Completed
Registry status
236
Enrollment target

NCT05566964 is a clinical trial that has completed, run by Ad scientiam. The registered enrollment target is 236 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05566964 has completed, sponsored by Ad scientiam.

COMPLETED
Registry status
236 participants
Enrollment target

Study Summary

The ME\&MGopen smartphone application is an investigational software for research purposes only, developed by Ad Scientiam. It features digital tests to assess the respiratory capacity ("My Breathing" Test), dysarthria ("My Voice" Test), ptosis ("My eyelids" test), as well as upper and lower limb muscle function ("My arms" Test and "My legs" Test). The mobile app also includes e-questionnaires related to activities of daily living, pain, insomnia, quality of life and depression. The objectives of the study are to collect data on patients' symptoms with the application in a real life setting, to assess adherence to the use of the tool, user experience and satisfaction with the application, and safety of use.

Interventions

  • DEVICE ME&MGopen smartphone application

Trial Details

FieldValue
Enrollment Target 236 participants
Start Date 2023-02-27
Est. Completion 2025-01-10

Sponsor

Ad scientiam

5 total trials

What the Registry Record Tells You About NCT05566964

The ClinicalTrials.gov registry entry for NCT05566964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ad scientiam, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ME&MGopen smartphone application is the first listed.

NCT05566964 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05566964 about?

NCT05566964 is a clinical study titled "Descriptive Analysis of Real-world Data Collected with ME&MGopen". The ME\&MGopen smartphone application is an investigational software for research purposes only, developed by Ad Scientiam. It features digital tests to assess the respiratory capacity ("My Breathing" Test), dysarthria ("My Voice" Test), ptosis ("My eyelids" test), as well as upper and lower limb mu...

What is the current status of trial NCT05566964?

This trial is currently completed. The enrollment target is 236 participants. The study started on 2023-02-27. Estimated completion is 2025-01-10.

What interventions are being tested in trial NCT05566964?

The interventions under investigation include: ME&MGopen smartphone application (DEVICE).

Who is sponsoring clinical trial NCT05566964?

This trial is sponsored by Ad scientiam, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.